Details for New Drug Application (NDA): 021197
✉ Email this page to a colleague
The generic ingredient in CETROTIDE is cetrorelix acetate. There is one drug master file entry for this compound. Seven suppliers are listed for this compound. Additional details are available on the cetrorelix acetate profile page.
Summary for 021197
Tradename: | CETROTIDE |
Applicant: | Emd Serono Inc |
Ingredient: | cetrorelix acetate |
Patents: | 0 |
Suppliers and Packaging for NDA: 021197
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CETROTIDE | cetrorelix acetate | POWDER;SUBCUTANEOUS | 021197 | NDA | EMD Serono, Inc. | 44087-1225 | 44087-1225-1 | 1 KIT in 1 CARTON (44087-1225-1) * 1 mL in 1 VIAL, GLASS * 1 mL in 1 SYRINGE, GLASS |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;SUBCUTANEOUS | Strength | EQ 0.25MG BASE/VIAL | ||||
Approval Date: | Aug 11, 2000 | TE: | AP | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | POWDER;SUBCUTANEOUS | Strength | EQ 3MG BASE/VIAL | ||||
Approval Date: | Aug 11, 2000 | TE: | RLD: | Yes |
Expired US Patents for NDA 021197
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Emd Serono Inc | CETROTIDE | cetrorelix acetate | POWDER;SUBCUTANEOUS | 021197-001 | Aug 11, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Emd Serono Inc | CETROTIDE | cetrorelix acetate | POWDER;SUBCUTANEOUS | 021197-001 | Aug 11, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Emd Serono Inc | CETROTIDE | cetrorelix acetate | POWDER;SUBCUTANEOUS | 021197-001 | Aug 11, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Emd Serono Inc | CETROTIDE | cetrorelix acetate | POWDER;SUBCUTANEOUS | 021197-002 | Aug 11, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Emd Serono Inc | CETROTIDE | cetrorelix acetate | POWDER;SUBCUTANEOUS | 021197-002 | Aug 11, 2000 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription